Related Experiment Video
Updated: Aug 12, 2026
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Coenzyme Q10 treatment in serious heart failure
H Munkholm1, H H Hansen, K Rasmussen
1Dept. of Cardiology, Aalborg Hospital, Denmark.
Biofactors (Oxford, England)
|July 23, 1999
Summary
Coenzyme Q10 supplementation improved cardiac function in heart failure patients. Invasive measurements confirmed enhanced left ventricular (LV) performance and reduced pulmonary pressures, suggesting coenzyme Q10 benefits for heart failure management.
Area of Science:
- Cardiology
- Biochemistry
- Pharmacology
Background:
- Noninvasive studies suggest coenzyme Q10 (CoQ10) benefits heart failure.
- Invasive validation is needed to confirm CoQ10's effects on cardiac function.
Purpose of the Study:
- To invasively assess the impact of CoQ10 on left ventricular (LV) performance in heart failure patients.
- To evaluate changes in hemodynamic parameters with CoQ10 treatment.
Main Methods:
- A randomized, double-blinded, placebo-controlled trial involving 22 heart failure patients (NYHA class 2-3).
- Patients received CoQ10 (100 mg twice daily) or placebo for 12 weeks.
- Right heart catheterization with exercise testing was performed before and after treatment.
Main Results:
- Significant improvements in stroke index at rest and during exercise.
- Significant reductions in pulmonary artery pressure and pulmonary capillary wedge pressure.
- Demonstrated enhancement of LV performance and reduced cardiac pressures.
Conclusions:
- Adjunctive treatment with CoQ10 may benefit patients with congestive heart failure.
- Invasive hemodynamic data support CoQ10's positive effects on cardiac function.
- CoQ10 shows potential as a therapeutic agent in managing heart failure.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...